Search Results
Site Search
Mayo Clinic Laboratories vector-borne disease testing is guided by an algorithm approach that supports the right test in the right region. Our comprehensive suite of vector-borne disease tests includes testing for the most commonly...
Mayo Clinic's Accurate Amyloidosis Typing Test Leads to Effective Treatment - Insights
When the type of amyloidosis is appropriately determined by accurate and effective laboratory testing, it can be treated properly.
Axonal autoimmune neuropathies - Insights
Find out about our panel-based approach to axonal autoimmune neuropathies, which we recommend because of the overlap in clinical symptoms.
Thrombotic microangiopathy (TMA) - Insights
View our comprehensive testing suite designed to confirm diagnosis and facilitate treatment of thrombotic microangiopathy.
Psychotropic PGx Panel for Drug Treatment Optimization [Test in Focus] - Insights
Ann Moyer, M.D., Ph.D. gives an overview of this new test available through Mayo Clinic Laboratories. She discusses when this testing should be ordered, how this testing improves upon other testing approaches, and what clinical action can...
Hereditary peripheral neuropathy - Insights
Learn how our test menu can assist in identifying genetic causes across the spectrum of hereditary peripheral neuropathies.
Jason Hipp, M.D., Ph.D., named chair of DLMP's new Division of Clinical Informatics - Insights
Dr. Hipp is a board-certified pathologist with fellowship training in pathology informatics, as well as artificial intelligence, machine, and deep-learning experience.
Mayo Clinic Laboratory and Pathology Research Roundup: Nov. 20 - Insights
This week’s Research Roundup highlights prehospital transfusion for gastrointestinal bleeding.
Mayo Clinic Laboratory and Pathology Research Roundup: Aug. 7 - Insights
This week’s Research Roundup highlights a randomized controlled trial of postoperative belladonna and opium rectal suppositories in vaginal surgery.
Mayo Clinic Laboratory and Pathology Research Roundup: May 28 - Insights
This week’s Research Roundup highlights the clinical and pathology findings associated consistently with larger glomerular volume.
Mayo Clinic Laboratory and Pathology Research Roundup: June 12 - Insights
This week’s Research Roundup highlights noninvasive assessment of renal fibrosis with magnetization transfer MR imaging.
What You Should Know about Rocky Mountain Spotted Fever - Insights
A Wisconsin woman has died of Rocky Mountain spotted fever in what Wisconsin health officials have confirmed is the first documented death from the infection in the state. Bobbi Pritt, M.D., Director of the Clinical Parasitology Laboratory...
Mayo Clinic Laboratory and Pathology Research Roundup: March 11 - Insights
This week’s Research Roundup highlights an assay to rapidly screen for immunoglobulin light chain glycosylation: a potential path to earlier AL diagnosis for a subset of patients and several other research articles by Mayo Clinic physicians...
Mayo Clinic Laboratory and Pathology Research Roundup: March 13 - Insights
This week’s Research Roundup highlights the clinical and pathological evolution of giant cell arteritis with a prospective study of follow-up temporal artery biopsies in 40 treated patients.
Tissue testing for COVID-19 - Insights
Being able to identify SARS-CoV-2 in tissue is key to better understand the virus that causes COVID-19. Now, a first-of-its-kind test that detects SARS-CoV-2 in formalin-fixed, paraffin-embedded tissue is available from Mayo Clinic...
Nonalcoholic Steatohepatitis (NASH)-FibroTest* [Test in Focus] - Insights
Nikola Baumann, Ph.D., gives an overview of the new NASH-FibroTest available through Mayo Clinic Laboratories. She discusses when this testing should be ordered, how this testing improves upon previous testing approaches, and what clinical...
Chromosomal microarray - Insights
Learn how our microarray evaluations identify, analyze, and assess clinically significant chromosomal abnormalities.
Hereditary epilepsy - Insights
Find out how we perform in-depth mutation and copy number variant analysis to determine causes of epilepsy and identify potential treatment options.
Newborn Screening at Mayo Clinic Laboratories
Newborn screening is intended to detect serious health conditions in babies for which early intervention can greatly improve healthy development and positive outcomes.
Mayo Clinic Laboratories’ BioPharma Diagnostics team facilitates customized collaborations with diagnostic companies to support their clinical and research testing needs.
Learn how our melanoma testing identifies variants in 17 genes associated with diagnosis, prognosis, and treatment guidance.
Rapid hereditary breast cancer - Insights
Learn how our rapid breast cancer treatment panel delivers results in 10 to 14 days and detects 11 genes linked to lifetime breast cancer risk.
Diagnostic and companion testing - Insights
Learn more about how diagnostic and companion testing can confirm a prenatal genetic diagnosis.
Week in Review: May 6 - Insights
Today's highlights include: Mental health needs rise as pandemic fluctuates, an algorithm that analyzes apple watch data shows early promise in detecting heart problems, and Minnesota physicians brace for Roe v. Wade decision
Week in Review: April 29 - Insights
Today's highlights include: CDC estimates 3 in 4 kids have had coronavirus infections, virtual in-person cardiac rehabilitation provide similar benefits, and Mayo Clinic partners with AI startup to co-develop precision medicine.
COVID-19 weekly news: March 7-11 2022 - Insights
Topic's Include: Losing sleep during the pandemic? It may be affecting your weight, heart, and overall health, and how to deal with anxiety, stress when the world feels overwhelming.
Explore how Mayo Clinic Laboratories’ focused myositis specific antibody (MSA) panel equips healthcare professionals with individualized insights to reduce diagnostic uncertainty and assist with the selection of tailored treatments for...
Mayo Clinic Laboratory and Pathology Research Roundup: Sept. 11 - Insights
This week’s Research Roundup highlights autologous mesenchymal stem cells, applied in a bioabsorbable matrix, for treatment of perianal fistulas in patients with Crohn's disease.
Mayo Clinic Laboratory and Pathology Research Roundup: May 7 - Insights
This week’s Research Roundup highlights how fasting blood-glucose levels provide estimate of duration and progression of pancreatic cancer before diagnosis.
Encephalitis caused by the immune system attacking the brain is similar in frequency to encephalitis from infections, Mayo Clinic researchers report in Annals of Neurology.
Research Suggests Genetics Are Key in Treating Night Sweats - Insights
Hormone therapy is often used to prevent night sweats. But finding the right dose of estrogen can be tricky, with some women needing more estrogen than others to get relief. A new Mayo Clinic study published in Menopause: The Journal of the...
Mayo Clinic Laboratory and Pathology Research Roundup: Nov. 13 - Insights
This week’s Research Roundup highlights how the DnaJ heat shock protein family B member 9 is a novel biomarker for fibrillary GN.
Mayo Clinic Laboratory and Pathology Research Roundup: Dec. 10 - Insights
This week’s Research Roundup highlights the evaluation of monoclonal gammopathy of renal significance: A consensus report of the International Kidney and Monoclonal Gammopathy Research Group.
Ann Moyer, M.D., Ph.D., Makes a Case for Pharmacogenomics - Insights
Pharmacogenomic testing is still limited, despite ample research, the existence of guidelines, and the emerging evidence it can help patients. Ann Moyer, M.D., Ph.D., Co-Director of the Personalized Genomics Laboratory at Mayo Clinic in...
Mayo Clinic Discovers Biological Markers That Could Guide Treatment for Prostate Cancer - Insights
Genetic alterations in low-risk prostate cancer diagnosed by needle biopsy can identify men that harbor higher-risk cancer in their prostate glands, Mayo Clinic has discovered.
Ticks and the Art of Finding Beauty in Dreadful, Wonderful Parasites - Insights
Bobbi Pritt, M.D., spends her work hours identifying and diagnosing infectious diseases. In her free time, she celebrates their beauty by creating bug-related artwork and blogging about parasites.
Mayo Clinic Laboratory and Pathology Research Roundup: Oct. 16 - Insights
This week’s Research Roundup highlights the role of deficient DNA mismatch repair status in patients with stage III colon cancer treated with FOLFOX adjuvant chemotherapy.
Mayo Clinic Laboratory and Pathology Research Roundup: Nov. 26 - Insights
This week’s Research Roundup highlights the effect of inorganic nitrite versus a placebo on exercise capacity among patients with heart failure with preserved ejection fraction.
Mayo Clinic Laboratory and Pathology Research Roundup: Jan. 14 - Insights
This week’s Research Roundup highlights the identification of prognostic phenotypes of esophageal adenocarcinoma in two independent cohorts.
Mayo Clinic Laboratory and Pathology Research Roundup: Aug. 20 - Insights
This week’s Research Roundup highlights how fasting blood glucose levels provide an estimate of duration and progression of pancreatic cancer before diagnosis.
MCL - Complement Component Deficiency and Hereditary Angioedema Patient Information - MC1235-313
MCL - Complement Component Deficiency and Hereditary Angioedema Patient Information
Mayo Clinic Laboratory and Pathology Research Roundup: April 17 - Insights
This week’s Research Roundup highlights autologous mesenchymal stem cells, applied in a bioabsorbable matrix, for treatment of perianal fistulas in patients with Crohn's disease.
Sudden cardiac death and episodes of fainting and seizures from long QT syndrome are significantly lower than previously thought when patients are diagnosed and treated at a specialty center dedicated to the treatment of genetic heart...
Sarcoma Targeted Gene Panel [Test in Focus] - Insights
Andre Oliveira, M.D., Ph.D., gives an overview of this testing available through Mayo Clinic Laboratories. He discusses when this testing should be ordered, how this testing compares to previous testing approaches, and what clinical action...
Primary ciliary dyskinesia - Insights
Learn more about Mayo Clinic Laboratories’ robust approach to testing for primary ciliary dyskinesia, a rare genetic condition that can lead to chronic otosinopulmonary disease and infertility in men.
Find out how our streamlined approach to fluorescence in situ hybridization testing can simplify the ordering process and better meet patient needs.
Learn about our full suite of leukemia testing protocols, including includes flow cytometry, chromosome, FISH, and molecular testing.
Browse our menu of MayoComplete next-generation sequencing assays which are designed to identify a growing list of hematological cancers.
Diagnosis and inflammation monitoring - Insights
Patients with symptoms that arouse clinical suspicion of either inflammatory bowel disease (IBD) or irritable bowel syndrome (IBS) are both common and tough to differentiate.
Hereditary neuromuscular disorders - Insights
Find out how our distinctive approach to evaluating for inherited neuromuscular disorders uses phenotypic information to streamline diagnosis.